Acquisition integrates advanced AI-driven patient engagement and operational tools into HOPCo’s expanding digital health and care navigation platforms
PHOENIX (Aug. 7, 2025) – Healthcare Outcomes Performance Company (HOPCo), the global leader in technology enabled musculoskeletal (MSK) outcomes management and value-based care, today announced the acquisition of Caro Health, a leading AI-powered digital health company based in Amsterdam, Netherlands. This strategic acquisition marks a significant advancement in HOPCo’s continued mission to build the most comprehensive global digital health platform for care delivery and a significant expansion of HOPCo’s growing European care footprint.
Caro Health, founded in 2019, has quickly emerged as a leader in conversational AI transforming how patients and medical providers consume and analyze disparate sources of data for use in decision making and patient interactions. Its proprietary AI platform is designed to deliver seamless, personalized communication at scale, both externally with patients and internally for providers. Currently deployed with nearly 40 healthcare customers across the Netherlands and Belgium, Caro’s technology supports several clinical specialties, including orthopedics and other MSK subspecialties.
“Our partnership with HOPCo enables us to accelerate our technology, expand our reach, and deliver intelligent, personalized healthcare communication on a global scale – faster and more effectively than ever before,” said Thomas Goijarts, Co-founder and CEO of Caro Health. “It will also allow us to better serve our local customers here in the Netherlands and across Europe by leveraging HOPCo’s clinical expertise and comprehensive digital platform and services. This will help us stay focused on our core strengths while speeding up the development of patient-centric, value-based technology solutions. We’re excited to be part of the HOPCo Digital Health team as we work to replicate the success we’ve achieved in Europe, in the United States.”
Goijarts will serve as Head of Products for HOPCo Digital and will report to HOPCo’s Global CIO, and Caro co-founder Guusje van der Heijden, will lead customer success and delivery for HOPCo in Europe, supporting both HOPCo’s established European clients and expanding HOPCo’s digital platform and services to Caro’s existing customer base. HOPCo plans to grow its new office in Europe by increasing resources to expand its international business and strengthen partnerships with its global base of clients. As part of the deal, Caro’s platform and team will be fully integrated into HOPCo’s Digital Health Division, aiding in the ongoing AI augmentation of products like HOPCo Vitals®, myrecovery by HOPCo®, HOPCo’s EMR Ecosystem and its cloud-based infrastructure for practices, ambulatory surgery centers, and health systems.
“We have been hugely impressed with Caro’s thoughtful approach to integrating conversational AI into complex clinical workflows,” said Dr. Tom Harte, President of HOPCo Digital. “The Caro team has clearly demonstrated that, when partnering with physicians to combine best-in-class technology with deep clinical expertise, conversational and generative AI can enhance both patient experience and operational workflow. This enables both physicians and administrators to focus on delivering patient care.”
With digital partnerships across the US, UK, Australia, and Europe, and as the only platform offering comprehensive, turn-key value-based care programs for population health, HOPCo is redefining MSK care by improving outcomes and reducing costs at scale. The acquisition of Caro Health strengthens HOPCo’s global digital platform and is expected not only transform patient experience across its markets but also drive substantial operational efficiencies for all of its partners.
“At HOPCo, we are building the most comprehensive digital platform globally with end-to-end products and services necessary to support practices, ambulatory surgery centers, health systems, and payors – from patient management to top-tier Cloud-based security,” said Chris Martinez, Global Chief Information Officer at HOPCo. “The integration of Caro Health’s innovative technology across our full suite of digital products and services will accelerate our AI roadmap and enable us to better support our customers across the globe in delivering high-quality, cost-effective care. Our time-to-value is crucial to our overall success, and we will continue to make strategic acquisitions, develop new products, and hire world-class engineering talent.”
About Healthcare Outcomes Performance Company (HOPCo)
Healthcare Outcomes Performance Company (HOPCo) is the global leader in musculoskeletal (MSK) value-based care, outcomes management, and care transformation. HOPCo partners with physician practices, health systems, payors, and suppliers to implement clinically integrated models that improve quality, reduce variability, and lower the total cost of MSK care.
Through HOPCo Digital, our advanced technology and AI platform, HOPCo is building the most comprehensive solution for practices, ambulatory surgery centers, payors, suppliers, and health systems enabling integrated, data-driven, and patient-centered care. HOPCo’s global footprint includes partnerships worldwide, with teams on the ground supporting successful implementations in both emerging and mature healthcare systems and markets.
Visit www.hopco.com to learn more.
About Caro Health
Caro Health is a European market leader in conversational AI for healthcare, transforming the patient journey and optimizing provider workflows. Acting as a digital companion, the platform offers tailored support, progress monitoring, and automated tools that integrate effortlessly with EHR systems. By alleviating administrative workloads and improving communication, Caro enables care teams to focus on delivering efficient, patient-focused care. Currently supporting almost 40 healthcare organizations across Europe, Caro is expanding its presence in hospitals and clinics, reshaping the connection between patients and providers throughout every stage of treatment.
###
For media inquiries, please contact:
David Lozano
Senior Director of Communications
Healthcare Outcomes Performance Company (HOPCo)
623.241.8779
David.lozano@hopco.com